Shuchi Nahar's Weekend Blog!

Advance Enzyme  Technologies Ltd  – Pioneers in Enzyme Biotechnology Twitter Handle: @shuchi_nahar Link: https://myweekendspot.blogspot.com/2020/12/what-are-enzyme-biotechnology-market.html Incorporated by second-generation enzymologists, the Rathi brothers in 1989, Advanced Enzyme Technologies (AET) is one of the largest research-driven Indian enzyme companies with a product basket of 400+ proprietary products developed from 68 indigenous enzymes and probiotics. Broadly, the business can be divided into three segments – 1) Human healthcare 2) Animal healthcare 3) Industrial processing. It manufactures enzymes by using natural resources such as plants, fungal, bacterial, and animal sources, using environment-friendly biotechnology processes. It offers these products to 700+ customers across 45 countries worldwide. Product Insights This classification provides break-up on the basis of the enzyme function. For example: 1) Proteases : They break down proteins (used in in

What are Enzyme Biotechnology, Market Size, and its Growth Drivers Twitter Handle: @shuchi_nahar Enzymes are proteins that catalyze chemical reactions and thus often replace chemicals in products and industrial productions. Biotechnology could be traced back to thousands of years ago when humans started to use yeasts to make liquor. This may be the first dawn of biotechnology in food production. Along with the development of natural and social sciences, nowadays, biotechnology carries more colorful meanings. Indian Enzyme Market The Indian enzyme market is yet to find its feet, as it is quite small when compared to the other sectors in the country. However, the growing awareness about the capabilities of enzymes and the subsequent benefits (both nutrition and cost-wise) will be important growth factors in the coming years.  The developments in pharmaceuticals and chemical sectors will provide much-needed boost to the enzyme market and it is expected that the demand for specialty

Natco Pharma - Pioneer of Indian Oncology Market - Company Overview Twitter Handle: @shuchi_nahar 1. Company Profile Natco Pharma (NPL) is a vertically integrated pharmaceutical company having presence in multiple speciality therapeutic segments. Over the years, the Company has developed an innate ability to deliver molecules, which are complex and hard to manufacture. The Company has constantly innovated and manufactured speciality medicines and niche pharmaceutical products. The company also has a US retail business. It owns 8 manufacturing facilities including 6 formulations facilities and 2 API facilities. Overall revenues grew at a CAGR of 15.4% in FY16-20. Natco is a leading domestic player in the oncology space. NPL’s product pipeline consists of drugs, which are used for various types of cancer like blood cancer, breast cancer, brain cancer, ovarian cancer, lung cancer and prostate cancer. Currently, Natco is marketing 33 oncology products in the Indian market (FY20). 2. Ma

Biocon Ltd. - Company Overview Twitter Handle: @shuchi_nahar Company Profile Biocon Limited is an Indian biopharmaceutical company based in Bangalore, India established as a joint venture between Ms. Kiran Mazumdar-Shaw and Biocon Biochemicals Limited, an Ireland based multinational. The Company manufactures generic active pharmaceutical ingredients (APIs) that are sold in over 120 countries across the globe, including the developed markets of the United States and Europe. It also manufactures novel biologics, as well as, biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets. In research services, Syngene International Limited (Syngene), a publicly listed subsidiary of Biocon, is engaged in the business of integrated endto-end drug discovery and development services. Biocon’s business is organized into the following reporting segments: · Sm